http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H10506906-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 |
| filingDate | 1995-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1998-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H10506906-A |
| titleOfInvention | Naphthyridinone derivatives |
| abstract | (57) Abstract: Formula I, including pharmaceutically acceptable salts thereof, Wherein R 1 is a phenyl C 1 -C 6 alkyl group (where the phenyl ring is one or several of the following: halogen, C 1 -C 4 alkyl group, C 1 -C 4 alkoxy group, R 2 represents C 2 -C 2 , which may be substituted by a hydroxy group or trifluoromethyl and the alkyl chain may be substituted by one or several C 1 -C 2 alkyl groups. 6 represents an alkoxycarbonyl group and R 3 represents hydrogen or halogen], which is an antirheumatic agent, and a modulator of cytokine synthesis, an immunomodulator, an anti-inflammatory agent and an antiallergic agent. Useful as an agent. Also described are compositions containing these compounds and methods for preparing these compounds. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010515712-A |
| priorityDate | 1994-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 100.